These findings collectively demonstrate that oral administration of BiHANs effectively alleviated IBD symptoms, as evidenced by reduced body weight loss, restored colon length, normalized spleen weight, lower DAI scores, and attenuated MPO activity. This evidence concerns the gene MPO and inflammatory bowel disease.